Loading...
506767 logo

Alkyl Amines Chemicals LimitedBSE:506767 Stock Report

Market Cap ₹97.9b
Share Price
n/a
1Y-7.8%
7D1.0%
1D-0.4%
Portfolio Value
View

Alkyl Amines Chemicals Limited

BSE:506767 Stock Report

Market Cap: ₹97.9b

Alkyl Amines Chemicals (506767) Stock Overview

Manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. More details

506767 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance4/6
Financial Health6/6
Dividends4/6

506767 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Alkyl Amines Chemicals Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Alkyl Amines Chemicals
Historical stock prices
Current Share Price₹1,914.55
52 Week High₹2,276.65
52 Week Low₹1,212.35
Beta0.61
1 Month Change0.82%
3 Month Change11.12%
1 Year Change-7.76%
3 Year Change-18.47%
5 Year Change-53.30%
Change since IPO42,445.56%

Recent News & Updates

Narrative Update Aug 06

506767: Upcoming Results Review Will Highlight Risk Of Overvalued Shares

The analyst fair value estimate for Alkyl Amines Chemicals has increased from about ₹1,596 to about ₹1,727, with analysts attributing this change to updated assumptions on revenue growth, profit margins and a higher future P/E multiple. What's in the News for Alkyl Amines Chemicals Alkyl Amines Chemicals has scheduled a board meeting on August 4, 2026.
Narrative Update Jun 24

506767: Upcoming Results Review Will Highlight Risk Of Overvalued Shares

Analysts have reduced their fair value estimate for Alkyl Amines Chemicals from ₹1,886.67 to ₹1,596.33, reflecting updated assumptions that include a lower projected P/E multiple, along with slightly revised views on the discount rate, revenue growth and profit margins. What's in the News for Alkyl Amines Chemicals Alkyl Amines Chemicals has scheduled a board meeting for May 5, 2026, to review the audited financial results for the quarter and financial year ended March 31, 2026.

Recent updates

Narrative Update Aug 06

506767: Upcoming Results Review Will Highlight Risk Of Overvalued Shares

The analyst fair value estimate for Alkyl Amines Chemicals has increased from about ₹1,596 to about ₹1,727, with analysts attributing this change to updated assumptions on revenue growth, profit margins and a higher future P/E multiple. What's in the News for Alkyl Amines Chemicals Alkyl Amines Chemicals has scheduled a board meeting on August 4, 2026.
Narrative Update Jun 24

506767: Upcoming Results Review Will Highlight Risk Of Overvalued Shares

Analysts have reduced their fair value estimate for Alkyl Amines Chemicals from ₹1,886.67 to ₹1,596.33, reflecting updated assumptions that include a lower projected P/E multiple, along with slightly revised views on the discount rate, revenue growth and profit margins. What's in the News for Alkyl Amines Chemicals Alkyl Amines Chemicals has scheduled a board meeting for May 5, 2026, to review the audited financial results for the quarter and financial year ended March 31, 2026.
Narrative Update Jun 10

506767: Upcoming Results Meeting Will Highlight Earnings Risk And Compressed Market Multiple

Analysts have cut their price target on Alkyl Amines Chemicals from ₹1,450 to ₹1,037, citing updated assumptions that include a lower estimated revenue growth rate, a slightly reduced discount rate, a higher projected profit margin, and a lower future P/E multiple. What's in the News A board meeting for Alkyl Amines Chemicals is scheduled on May 5, 2026, to consider and approve audited financial results for the quarter and financial year ended March 31, 2026.
Narrative Update May 27

506767: Upcoming Board Meeting And Final Dividend Decision May Support Bullish Repricing

Analysts have lifted the fair value estimate for Alkyl Amines Chemicals slightly from ₹1,990 to ₹2,032, citing refreshed assumptions around revenue growth, profit margins and future P/E as drivers of the updated price target. What's in the News Board meeting scheduled for May 5, 2026, to consider and approve audited financial results for the quarter and financial year ended March 31, 2026 (Key Developments) Board to consider recommendation of a final dividend on the equity shares for the financial year ended March 31, 2026, if any (Key Developments) Valuation Changes Fair Value: Adjusted slightly from ₹1,990 to ₹2,032, reflecting refreshed assumptions in the model.
Narrative Update May 08

506767: Upcoming Board Meeting And Dividend Decision May Support Bullish Repricing

Analysts have reset their price target on Alkyl Amines Chemicals from ₹3,049 to ₹1,990. This reflects updated assumptions around lower revenue growth, profit margins and future P/E, partly offset by a reduced discount rate.
Narrative Update Apr 23

506767: Upcoming Results Meeting Will Clarify Earnings Assumptions And Fair Value

Analysts have trimmed their price target for Alkyl Amines Chemicals from ₹1,730 to ₹1,450, citing updated assumptions on discount rates, revenue growth, profit margins and a lower future P/E multiple. What's in the News Board meeting scheduled for May 5, 2026, to consider and approve audited financial results for the quarter and year ended March 31, 2026 (Key Developments) Board to consider recommendation of a final dividend on equity shares for the financial year ended March 31, 2026, if any (Key Developments) Valuation Changes Fair Value: The analyst fair value estimate has been revised from ₹1,730 to ₹1,450, a reduction of about 16%.
Narrative Update Apr 07

506767: Upcoming Results Meeting Will Support Confidence In Fair Value

Analysts have maintained the price target for Alkyl Amines Chemicals at ₹1,730. The latest updates reflect adjusted assumptions on discount rate, revenue growth, profit margin and future P/E to support this valuation.
Narrative Update Mar 24

506767: Upcoming Results Review Will Support Bullish Long Term Outlook

Analysts have trimmed their price target on Alkyl Amines Chemicals from about ₹2,177 to roughly ₹1,887, reflecting updated assumptions around fair value, discount rate, profit margin and expected future P/E multiples. What's in the News A board meeting is scheduled for February 3, 2026, to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2025 (company filing).
Narrative Update Mar 09

506767: Upcoming Board Review Will Support Bullish Long Term Outlook

Narrative Update The analyst price target for Alkyl Amines Chemicals has been adjusted from ₹2,256 to ₹2,177, with analysts citing updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News A board meeting is scheduled for February 3, 2026, to review and approve unaudited financial results for the quarter and nine months ended December 31, 2025 (company filing).
Narrative Update Feb 23

506767: Steady Fair Value And Upcoming Results Will Support Future Upside

Analysts have kept their fair value estimate for Alkyl Amines Chemicals steady at ₹1,730, with only modest tweaks to assumptions such as discount rate, revenue growth, profit margin, and future P/E supporting this unchanged price target. What's in the News A board meeting is scheduled for February 3, 2026, to review and approve unaudited financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
Narrative Update Feb 07

506767: Upcoming Board Decisions On Results And Remuneration Will Support Future Upside

Analysts have trimmed their price target on Alkyl Amines Chemicals from ₹1,835 to ₹1,730 as they factor in updated assumptions for revenue growth, profit margins and future P/E, alongside a slightly lower discount rate. What's in the News Board meeting scheduled for February 3, 2026 to review and approve unaudited financial results for the quarter and nine months ended December 31, 2025, which could update you on recent operating and financial trends (company filing).
Narrative Update Jan 24

506767: Board And Remuneration Decisions Will Support Future Upside Potential

Analysts have held their price target for Alkyl Amines Chemicals steady at ₹1,835, citing only small tweaks to assumptions on discount rate, revenue growth, profit margin and future P/E that they view as too minor to warrant a change in fair value. What's in the News A board meeting is scheduled for February 3, 2026, to consider approval of unaudited financial results for the quarter and nine months ended December 31, 2025 (Key Developments).
Narrative Update Jan 09

506767: Remuneration Decisions And Revised Assumptions Will Support Future Upside Potential

Analysts have reduced their price target on Alkyl Amines Chemicals from ₹2,031 to ₹1,835, citing slightly lower assumptions for revenue growth, profit margins, discount rate, and future P/E multiples in their models. What's in the News A special or extraordinary shareholders meeting is scheduled for December 20, 2025, via postal ballot in India to consider revising the remuneration of Whole Time Director Operations, Mr. Rakesh S.
Narrative Update Dec 23

506767: Upcoming Meeting And Remuneration Review Will Support Bullish Outlook

Analysts have modestly revised their price target on Alkyl Amines Chemicals to ₹2,256.00, reflecting slightly higher discount rate and forward P/E assumptions while keeping long term growth and margin expectations broadly unchanged. What's in the News A board meeting is scheduled for November 4, 2025, to review unaudited financial results for the quarter and half year ended September 30, 2025, and to consider a revision in remuneration for key management.
Narrative Update Dec 09

506767: Upcoming Board Meeting Will Drive Fresh Momentum Into Next Year

Analysts have maintained their price target for Alkyl Amines Chemicals at ₹2,256 per share, with only marginal tweaks to the discount rate and long-term valuation inputs, reflecting continued confidence in the companys growth and profitability profile. What's in the News Board meeting scheduled for November 04, 2025, to approve unaudited financial results for the quarter and half year ended September 30, 2025, and to consider a revision in remuneration (Key Developments) Special and extraordinary shareholders meeting to be conducted via postal ballot in India on December 20, 2025 (Key Developments) Valuation Changes Fair Value: Maintained at ₹2,256 per share, indicating no change in the intrinsic value estimate.
Narrative Update Nov 25

506767: Upcoming Board Meeting Will Drive Fresh Momentum Into Next Year

Narrative Update on Alkyl Amines Chemicals Analysts have adjusted their price target for Alkyl Amines Chemicals downward from ₹2,423.50 to ₹2,256.00, citing more conservative expectations for the company's future revenue growth and profit margins. What's in the News A Special or Extraordinary Shareholders Meeting is scheduled for December 20, 2025 and will be conducted via postal ballot in India (Key Developments) A Board Meeting is set for November 4, 2025 at 11:45 Indian Standard Time.
Narrative Update Aug 06

New Ethylamine Plant Will Support Growing Market Demand

The upward revision in Alkyl Amines Chemicals’ consensus analyst price target from ₹2204 to ₹2415 is primarily driven by a higher future P/E multiple, indicating increased optimism for the company’s earnings potential. Valuation Changes Summary of Valuation Changes for Alkyl Amines Chemicals The Consensus Analyst Price Target has risen from ₹2204 to ₹2415.
User avatar
New Narrative Feb 09

New Ethylamine Plant Will Support Growing Market Demand

Developing higher-grade acetonitrile and specialty chemicals could improve pricing, net margins, and revenue streams in emerging markets.

Shareholder Returns

506767IN ChemicalsIN Market
7D1.0%0.6%-0.4%
1Y-7.8%1.9%4.6%

Return vs Industry: 506767 underperformed the Indian Chemicals industry which returned 2.3% over the past year.

Return vs Market: 506767 underperformed the Indian Market which returned 4.8% over the past year.

Price Volatility

Is 506767's price volatile compared to industry and market?
506767 volatility
506767 Average Weekly Movement5.8%
Chemicals Industry Average Movement6.0%
Market Average Movement5.9%
10% most volatile stocks in IN Market8.9%
10% least volatile stocks in IN Market3.6%

Stable Share Price: 506767 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 506767's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1979733Yogesh Kotharialkylamines.com

Alkyl Amines Chemicals Limited manufactures and supplies amines, amine derivatives, and other specialty chemicals in India and internationally. The company offers aliphatic amines, such as methylamines, ethylamines, isopropylamines, n-propylamines, n-butylamines, ethylhexylamines, furfurylamines, n-propylamines, and cyclohexylamines; and amine derivatives, including dimethylamine hydrochloride, diethylamine hydrochloride, triethylamine hydrochloride, dimethylaminopropylamine, 3-ethoxy propylamine, 3-(methylaminopropyl) amine, dimethylaminopropylamine, 3-(2-ethylhexyloxy) propylamine, n-methylbenzylamine, diisopropyl ethylamine, diethylhydroxylamine, diethyl toluamide, and diethylphenyl acetamide. It also provides specialty chemicals comprising acetonitrile, 1,8-diazabicyclo[5.4.0]undec-7-ene, diethylketone/3-pentanone, alchan 100, alchan 300, 2-aminoethoxy ethanol, 2-ethoxy ethylamine, dimethylpropyleneurea, tetramethyl ethylenediamine, monomethylamine, and tempo free radical.

Alkyl Amines Chemicals Limited Fundamentals Summary

How do Alkyl Amines Chemicals's earnings and revenue compare to its market cap?
506767 fundamental statistics
Market cap₹97.92b
Earnings (TTM)₹2.25b
Revenue (TTM)₹16.58b
43.5x
P/E Ratio
5.9x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
506767 income statement (TTM)
Revenue₹16.58b
Cost of Revenue₹8.89b
Gross Profit₹7.69b
Other Expenses₹5.44b
Earnings₹2.25b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)44.03
Gross Margin46.39%
Net Profit Margin13.58%
Debt/Equity Ratio0.08%

How did 506767 perform over the long term?

See historical performance and comparison

Dividends

0.5%
Current Dividend Yield
28%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/14 03:21
End of Day Share Price 2026/08/14 00:00
Earnings2026/06/30
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alkyl Amines Chemicals Limited is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ashwin MehtaAmbit Capital
Kumar Saumya SinghAmbit Capital
Kameswari V. S. ChavaliFirstCall Research